TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Primary Immunodeficiency and Inherited Metabolic Disorders in Children

Recruiting

Phase 2

TCR Alpha Beta HCTTCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Primary Immunodeficiency and Inherited Metabolic Disorders in Children

Sponsor:

Johns Hopkins All Children's Hospital

Code:

NCT04414046

Conditions

Primary Immune Deficiency Disorders

Metabolic Disease

Eligibility Criteria

Sex: All

Age: 0 - 21

Healthy Volunteers: Not accepted

Interventions

Haploidentical Hematopoietic Cell Transplantation

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2026-05-13. This information was provided to ClinicalTrials.gov by Johns Hopkins All Children's Hospital on 2025-06-24.